Codexis Inc (CDXS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.07
• Market Cap: $101.16M
• EPS: $-0.73
• 52-Week High: $3.87
• 52-Week Low: $1.05

Market Sentiment

Codexis Inc currently has a Neutral sentiment score of -0.04.

About Codexis Inc

Codexis, Inc. is an innovative biotechnology company based in Redwood City, California, focused on the discovery, development, and commercialization of advanced biocatalysts that drive more sustainable manufacturing across diverse sectors, including pharmaceuticals, chemicals, and food. Utilizing its proprietary enzyme technology and cutting-edge protein engineering techniques, Codexis enhances enzyme performance, establishing itself as a leader in biocatalyst applications. As global industri...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Codexis Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CDXS pay dividends?

Codexis Inc (CDXS) does not currently pay a regular dividend.

What is CDXS's market cap?

Codexis Inc (CDXS) has a market capitalization of $101.16M with a current stock price of $1.07.